Results 21 to 30 of about 9,872 (176)

Durability of a bovine pericardial aortic bioprosthesis based on Valve Academic Research Consortium-3 echocardiographic criteriaCentral MessagePerspective

JTCVS Open, 2022
Objectives: The Carpentier-Edwards Perimount Magna Ease (Edwards Lifesciences) pericardial bioprosthesis has demonstrated satisfying hemodynamics at midterm follow-up, but its durability remains unclear.
Stéphane Kermen, MD, Juliette Strella, MD, Arthur Aupart, MD, Fabien Espitalier, MD, Michel Aupart, MD, Anne Bernard, MD, PhD, Thierry Bourguignon, MD, PhD   +6 more
doaj   +1 more source

O conduto valvulado bovino contegra, um biomaterial para o tratamento cirúrgico de cardiopatias congênitas The contegra valved bovine conduit: a biomaterial for the surgical treatment of congenital heart defects

Arquivos Brasileiros de Cardiologia, 2012
O Contegra, um enxerto de veia jugular bovina, tem sido amplamente utilizado como biomaterial de preferência no tratamento cirúrgico das cardiopatias congênitas, especialmente como um conduto para a reconstrução da via de saída ventricular direita.
Shi-Min Yuan
doaj   +3 more sources

Calcification and Oxidative Modifications Are Associated With Progressive Bioprosthetic Heart Valve Dysfunction

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2017
Background Bioprosthetic heart valves (BHVs), fabricated from glutaraldehyde‐pretreated bovine pericardium or porcine aortic valves, are widely used for the surgical or interventional treatment of heart valve disease.
Suengwon Lee, Robert J. Levy, Abigail J. Christian, Stanley L. Hazen, Nathan E. Frick, Eric K. Lai, Juan B. Grau, Joseph E. Bavaria, Giovanni Ferrari   +8 more
doaj   +1 more source

Undiagnosed mitroflow bioprosthesis deformation causing early structural valve deterioration

, 2017
Bioprosthesis are commonly used in the elderly population. Structural valve deterioration affects the long-term durability. We report an early deterioration of a Mitroflow valve caused by ring deformation and prosthetic leaflet rupture.
Annoni A, Mara Rubino, Gennari M, Rubino M, M. Agrifoglio, Gianluca Polvani, Francesco Arlati, Arlati F, Marco Gennari, Andrea Annoni, Marco Agrifoglio, G. Polvani   +11 more
core   +1 more source

Tratamento cirúrgico das valvopatias aórticas com bioprótese de pericárdio bovino sem suporte: resultados imediatos Surgical treatment of aortic valve disease with stentless bovine pericardium prosthesis: immediate results

Arquivos Brasileiros de Cardiologia, 2006
OBJETIVO: Apresentar os resultados imediatos e avaliar o desempenho clínico e hemodinâmico das biopróteses sem suporte de pericárdio bovino (stentless) em posição aórtica.
Wesley Ferreira de Araújo, Luis Roberto Gerola, Hyoung C. Kin, Armindo Pereira Filho, Guilherme Flora Vargas, Roberto Catani, Enio Buffolo   +6 more
doaj   +1 more source

Real-world early- to midterm outcomes of aortic valve replacement using novel tissue technology bioprosthesis at a high-volume centerCentral MessagePerspective

JTCVS Open
Objective: The INSPIRIS-RESILIA aortic valve (Edwards Lifesciences) uses a novel tissue-fixation technology to enhance the bioprosthesis's longevity. We sought to report midterm INSPIRIS-RESILIA aortic bioprosthesis performance in a large contemporary ...
Emily Vianna, MD, Patrick R. Vargo, MD, L. Leonardo Rodriguez, MD, Salvatore Poddi, MD, Kelsey Curran, MPH, Jeevanantham Rajeswaran, PhD, Shinya Unai, MD, Eric E. Roselli, MD, Lars G. Svensson, MD, PhD, Haytham Elgharably, MD, PhD   +9 more
doaj   +1 more source

Comparison of the Performance of a Sutureless Bioprosthesis With Two Pericardial Stented Valves on Small Annuli: An In Vitro Study

, 2016
Aortic valve replacement has evolved recently with the development of the sutureless bioprosthesis. One such valve is the Perceval bioprosthesis, which is built by mounting leaflets of bovine pericardium to a thin stent; this approach has the potential ...
M. Contino, C. Romagnoni, G. B. Fiore, C. Antona, TASCA, GIORDANO, MANGINI, ANDREA, REDAELLI, ALBERTO CESARE LUIGI, Romagnoni, Claudia, G. Tasca, FIORE, GIANFRANCO BENIAMINO, A. Redaelli, R. Vismara, Contino, Monica, VISMARA, RICCARDO, Antona, Carlo, A. Mangini   +15 more
core   +1 more source

Frailty and Five‐Year Mortality After TAVR in Patients Aged 75 Years and Older

Journal of the American Geriatrics Society, EarlyView.
In patients aged 75 years and older undergoing transcatheter aortic valve replacement, frailty assessed by the Clinical Frailty Scale was the most robust geriatric factor independently associated with five‐year mortality. This study highlights the specific prognostic value of frailty beyond short‐term outcomes.
Jérémie Huet, Mélissa Sabin, Thierry Le Tourneau, Thibaut Manigold, Anne‐Sophie Boureau   +4 more
wiley   +1 more source

Biomechanical analysis of novel leaflet geometries for bioprosthetic valvesCentral MessagePerspective

JTCVS Open, 2023
Objectives: Although bioprosthetic valves have excellent hemodynamic properties and can eliminate the need for lifelong anticoagulation therapy, these devices are associated with high rates of reoperation and limited durability.
Pearly K. Pandya, BS, Matthew H. Park, MS, Yuanjia Zhu, MS, MD, Y. Joseph Woo, MD   +3 more
doaj   +1 more source

Mechanisms and Management of Acquired Aseptic Intracardiac Communications After Transcatheter Aortic Valve Implantation: Single‐Center Case Series Insights

Catheterization and Cardiovascular Interventions, Volume 108, Issue 6, Page 2243-2254, November 15, 2026.
ABSTRACT Background Acquired aseptic intracardiac communications (AICCs) are rare but clinically relevant structural complications following transcatheter aortic valve implantation (TAVI), typically resulting from mechanical injury to the aortic annulus, interventricular septum, or adjacent structures.
Geza Fontos, Abdelkrim Ahres, Marton Vertesaljai, Tunde Pinter, Zsolt Piroth, Matyas Pal, Peter Andreka   +6 more
wiley   +1 more source